Inhaled fluid with pH below 3.0 targets respiratory pathogens via acid-mediated disruption, offering broad-spectrum efficacy without systemic toxicity.
GM-ACT leaves provide high-activity oxalate oxidase to reduce oxalate levels in tea, mitigating kidney stone risk without altering beverage consumption.
VHH antibodies target the spike protein receptor-binding domain to neutralize SARS-CoV-2 variants while reducing production costs.
A nasal hepatitis B vaccine composition utilizes a gel base material treated with outside shearing force to enhance spray performance.
Micronized glycerol emulsions overcome powder clumping to ensure stable storage and reliable dosing.
Miraculin adjusts pH to reduce perceived saltiness, resolving the trade-off between cleansing efficacy and patient compliance.